Last reviewed · How we verify

NCT05966428

Sensory Integration Therapy and Cerebral Palsy

Completed NA Last updated 28 July 2023
What this trial tests

NA trial testing Conventional Exercises in Cerebral Palsy in 24 participants. Completed in 1 June 2018.

Timeline
1 January 2018
Primary endpoint
1 May 2018
1 June 2018

Quick facts

Lead sponsorKirsehir Ahi Evran Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date1 January 2018
Primary completion1 May 2018
Estimated completion1 June 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 4 to 17, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This intervention study was planned to investigate the effects of Sensory Integration Therapy that added to the conventional therapy program on spasticity, balance, motor function and functional independency levels of children with spastic diplegic cerebral palsy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Conventional Exercises

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05966428.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing